Real world outcome analysis of treosulfan-based conditioning prior to allo-HCT in patients with MDS compared to clinical trial data

Affiliations

• ¹ Department of Medicine/Hematology and Oncology, University Hospital of Muenster, Muenster, Germany. matthias.stelljes@ukmuenster.de.
• ² Department of Internal Medicine, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
• ³ Department of Medicine/Hematology and Oncology, University Hospital of Muenster, Muenster, Germany.
• ⁴ Department of Bone Marrow Transplantation, West German Cancer Centre, University of Duisburg-Essen, Essen, Germany.
• ⁵ Department of Haematology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszów, Poland.
• ⁶ Department of Haematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Lyon, France.
• ⁷ St István and St László Hospital of Budapest, Budapest, Hungary.
• ⁸ Haematology and Bone Marrow Transplantation Unit, Istituto di Ricovero e Cura a Carattere Scientifico, San Raffaele Scientific Institute, Milan, Italy.
• ⁹ medac GmbH, Wedel, Germany.
• ¹⁰ Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.